Report Detail
Global Biopharmaceuticals Contract Manufacturing Market By Source, Service (Process Development, Analytical & QC Studies), Product (Biologics, Biosimilars), and Segment - Market Research Report 2021 : Covid 19 Impact Outlook, Regional Analysis, Competitive Landscape, Growth Prospects & Forecast 2020-2026
- RnM4285186 |
- 10 February, 2021 |
- Global |
- 205 Pages |
- Transilience Market Research |
- Healthcare
Global Biopharmaceuticals Contract Manufacturing Market Analysis Report By Source, Service (Process Development, Analytical & QC Studies), Product (Biologics, Biosimilars), and Segment - Global Forecast and COVID Impact Outlook 2020-2026
Biopharmaceuticals Contract Manufacturing Market is valued at 13.87 USD Billion in 2019 and expected to reach USD 25.67 Billion by 2026 with the CAGR of 9.19% over the forecast period.
Scope of the report
This report analyses the global market for Biopharmaceuticals Contract Manufacturing. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.
Key Players
Boehringer Ingelheim GmbH, Lonza, Inno Biologics Sdn Bhd, Rentschler Biotechnologie GmbH, JRS PHARMA, AGC Biologics, ProBioGen, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., TOYOBO CO., LTD, Samsung BioLogics, Thermo Fisher Scientific, Inc., Binex Co., Ltd., WuXi Biologics, AbbVie, Inc. and others
Above mentioned companies were scrutinized to assess competitive landscape of global Biopharmaceuticals Contract Manufacturing market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.
Review period:
(2016-2026)
Historic Period: 2016 to 2019
Forecast Period: 2020 to 2026
Base Year: 2019
Unit: USD Billion
This Biopharmaceuticals Contract Manufacturing market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, capacity analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.
Regions
• North America: U.S., Canada and Rest of North America
• Europe: UK, France, Germany, Italy, Spain and Rest of Europe
• Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific
• Latin America: Brazil, Mexico, Argentina and Rest of Latin America
• Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa
Market Segmentation
• Source
o Mammalian
o Non-mammalian
• Service
o Process Development
o Fill & Finish Operations
o Analytical & QC Studies
o Packaging
• Product
o Biologics
o Biosimilars
Report Coverage
• An overview of the global Biopharmaceuticals Contract Manufacturing market
• In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market
• Global Biopharmaceuticals Contract Manufacturing market revenue data historic and forecast analysis (2016 to 2026)
• Characterization and quantification of the market segments for Biopharmaceuticals Contract Manufacturing market
• Market share analysis of key market participants and their competitive landscape
Important Questions Answered by Global Biopharmaceuticals Contract Manufacturing Market Report
• What is the impact of COVID 19 epidemic on the global Biopharmaceuticals Contract Manufacturing market?
• Which is mostly affected region, country?
• Which is the current largest and fastest-growing region?
• What is the market size and growth rate of the global Biopharmaceuticals Contract Manufacturing market?
• What are current factors affecting the growth of market?
• What are Key trends and opportunity areas?
• Within Biopharmaceuticals Contract Manufacturing market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?
• What are the major strategies adopted by leading market companies?
• What are company challenges and essential success factors by marketsegment?
• How company offerings and supply chain capabilitiesare shifting to meetemerging market needs?
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. List of Abbreviations
2. Executive Summary
3. Market Overview
- 3.1. Market Definition
- 3.2. Market Scope
- 3.3. Market Drivers
- 3.4. Market Restraints
- 3.5. Market Opportunities and Trends
- 3.6. Porter’s five force analysis
- 3.7. SWOT Analysis
- 3.8. PEST Analysis
- 3.9. Patent Analysis
- 3.10. Impact of COVID 19 on Global Biopharmaceuticals Contract Manufacturing Market
4. Biopharmaceuticals Contract Manufacturing Market, By Source , Market Size and Forecast 2016 -2026 (USD Billion)
- 4.1. Global Biopharmaceuticals Contract Manufacturing Market By Source , 2016 -2026 (USD Billion)
- 4.1.1. Global Biopharmaceuticals Contract Manufacturing Market By Mammalian
- 4.1.2. Global Biopharmaceuticals Contract Manufacturing Market By Non-mammalian
- 4.2. Global Biopharmaceuticals Contract Manufacturing Market By Source Share, 2016 -2026 (%)
5. Biopharmaceuticals Contract Manufacturing Market, By Service , Market Size and Forecast 2016 -2026 (USD Billion)
- 5.1. Global Biopharmaceuticals Contract Manufacturing Market By Service ,2016 -2026 (USD Billion)
- 5.1.1. Global Biopharmaceuticals Contract Manufacturing Market By Process Development
- 5.1.2. Global Biopharmaceuticals Contract Manufacturing Market By Fill & Finish Operations
- 5.1.3. Global Biopharmaceuticals Contract Manufacturing Market By Analytical & QC Studies
- 5.1.4. Global Biopharmaceuticals Contract Manufacturing Market By Packaging
- 5.2. Global Biopharmaceuticals Contract Manufacturing Market By Service Share, 2016 -2026 (%)
6. Biopharmaceuticals Contract Manufacturing Market, By Product , Market Size and Forecast 2016 -2026 (USD Billion)
- 6.1. Global Biopharmaceuticals Contract Manufacturing Market By Product , 2016 -2026 (USD Billion)
- 6.1.1. Global Biopharmaceuticals Contract Manufacturing Market By Biologics
- 6.1.2. Global Biopharmaceuticals Contract Manufacturing Market By Biosimilars
- 6.2. Global Biopharmaceuticals Contract Manufacturing Market By Product Share, 2016 -2026 (%)
7. Biopharmaceuticals Contract Manufacturing Market, By Region Market Size and Forecast 2016 -2026
- 7.1. NORTH AMERICA
- 7.1.1. Key Findings
- 7.1.2. Impact of COVID 19
- 7.1.3. Key market trends, growth factors and opportunities
- 7.1.4. North America Biopharmaceuticals Contract Manufacturing Market by Country 2016 -2026 (USD Billion)
- 7.1.5. North America Biopharmaceuticals Contract Manufacturing Market By Source 2016 -2026 (USD Billion)
- 7.1.6. North America Biopharmaceuticals Contract Manufacturing Market By Service 2016 -2026 (USD Billion)
- 7.1.7. North America Biopharmaceuticals Contract Manufacturing Market By Product 2016 -2026 (USD Billion)
- 7.2. EUROPE
- 7.2.1. Key Findings
- 7.2.2. Impact of COVID 19
- 7.2.3. Key market trends, growth factors and opportunities
- 7.2.4. Europe Biopharmaceuticals Contract Manufacturing Market by Country 2016 -2026 (USD Billion)
- 7.2.5. Europe Biopharmaceuticals Contract Manufacturing Market By Source 2016 -2026 (USD Billion)
- 7.2.6. Europe Biopharmaceuticals Contract Manufacturing Market By Service 2016 -2026 (USD Billion)
- 7.2.7. Europe Biopharmaceuticals Contract Manufacturing Market By Product 2016 -2026 (USD Billion)
- 7.3. ASIA PACIFIC
- 7.3.1. Key Findings
- 7.3.2. Impact of COVID 19
- 7.3.3. Key market trends, growth factors and opportunities
- 7.3.4. Asia Pacific Biopharmaceuticals Contract Manufacturing Market by Country 2016 -2026 (USD Billion)
- 7.3.5. Asia Pacific Biopharmaceuticals Contract Manufacturing Market By Source 2016 -2026 (USD Billion)
- 7.3.6. Asia Pacific Biopharmaceuticals Contract Manufacturing Market By Service 2016 -2026 (USD Billion)
- 7.3.7. Asia Pacific Biopharmaceuticals Contract Manufacturing Market By Product 2016 -2026 (USD Billion)
- 7.4. LATIN AMERICA
- 7.4.1. Key Findings
- 7.4.2. Impact of COVID 19
- 7.4.3. Key market trends, growth factors and opportunities
- 7.4.4. Latin America Biopharmaceuticals Contract Manufacturing Market by Country 2016 -2026 (USD Billion)
- 7.4.5. Latin America Biopharmaceuticals Contract Manufacturing Market By Source 2016 -2026 (USD Billion)
- 7.4.6. Latin America Biopharmaceuticals Contract Manufacturing Market By Service 2016 -2026 (USD Billion)
- 7.4.7. Latin America Biopharmaceuticals Contract Manufacturing Market By Product 2016 -2026 (USD Billion)
- 7.5. MIDDLE EAST AND AFRICA
- 7.5.1. Key Findings
- 7.5.2. Impact of COVID 19
- 7.5.3. Key market trends, growth factors and opportunities
- 7.5.4. Middle East and Africa Biopharmaceuticals Contract Manufacturing Market by Country 2016 -2026 (USD Billion)
- 7.5.5. Middle East and Africa Biopharmaceuticals Contract Manufacturing Market By Source 2016 -2026 (USD Billion)
- 7.5.6. Middle East and Africa Biopharmaceuticals Contract Manufacturing Market By Service 2016 -2026 (USD Billion)
- 7.5.7. Middle East and Africa Biopharmaceuticals Contract Manufacturing Market By Product 2016 -2026 (USD Billion)
8. Competitive Landscape Analysis
- 8.1. Global Biopharmaceuticals Contract Manufacturing Market Company Revenue, (USD Billion), 2016-2019
- 8.2. Global Biopharmaceuticals Contract Manufacturing Market Company Share, (%), 2016-2019
9. Company Profiles
- 9.1. Boehringer Ingelheim GmbH
- 9.2. Lonza
- 9.3. Inno Biologics Sdn Bhd
- 9.4. Rentschler Biotechnologie GmbH
- 9.5. JRS PHARMA
- 9.6. AGC Biologics
- 9.7. ProBioGen
- 9.8. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
- 9.9. TOYOBO CO., LTD
- 9.10. Samsung BioLogics
- 9.11. Thermo Fisher Scientific, Inc.
- 9.12. Binex Co., Ltd.
- 9.13. WuXi Biologics
- 9.14. AbbVie, Inc.
- 9.15. Others
10. Appendix
11. List of Tables
12. List of Figures
Summary:
Get latest Market Research Reports on Biopharmaceuticals Contract Manufacturing . Industry analysis & Market Report on Biopharmaceuticals Contract Manufacturing is a syndicated market report, published as Global Biopharmaceuticals Contract Manufacturing Market By Source, Service (Process Development, Analytical & QC Studies), Product (Biologics, Biosimilars), and Segment - Market Research Report 2021 : Covid 19 Impact Outlook, Regional Analysis, Competitive Landscape, Growth Prospects & Forecast 2020-2026. It is complete Research Study and Industry Analysis of Biopharmaceuticals Contract Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
